Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome.
Kataoka A, Mizumoto C, Kanda J, Iwasaki M, Sakurada M, Oka T, Fujimoto M, Yamamoto Y, Yamashita K, Nannya Y, Ogawa S, Takaori-Kondo A.
Kataoka A, et al.
Int J Hematol. 2023 Jun;117(6):919-924. doi: 10.1007/s12185-023-03532-y. Epub 2023 Jan 14.
Int J Hematol. 2023.
PMID: 36641501